During the past decade, District Hospital Kufstein conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "District Hospital Kufstein" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Cephalon" with 1 trials as a collaborator and "Ebewe Pharma GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "District Hospital Kufstein" are "Breast Cancer" (3 trials) and "Colorectal Carcinoma" (1 trials). Many other conditions were trialed in "District Hospital Kufstein" in a lesser frequency.

Most popular intervention types in "District Hospital Kufstein" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials), "Docetaxel" (1 trials), "Epirubicin" (1 trials), "Trastuzumab" (1 trials) and "Trastuzumab+Docetaxel+NPLD" (1 trials). Other intervention names were less common.

The vast majority of trials in "District Hospital Kufstein" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "District Hospital Kufstein". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in District Hospital Kufstein, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in District Hospital Kufstein, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".